Special surgical approaches during peri-COVID-19 pandemic: Robotic and transanal minimally invasive surgery

Luis Sánchez-Guillén1, Rosa M Jimenez-Rodriguez2

  • 1Department of Cirugía General, Hospital Universitario de Elche, Elche 03201, Spain.

Insights

Robotic and transanal minimally invasive surgery (MIS) for colorectal diseases can be safely performed during the coronavirus disease 2019 pandemic. However, specific procedural considerations are essential for safe execution.

Area of Science:

  • Colorectal Surgery
  • Minimally Invasive Surgery (MIS)
  • Robotic Surgery
  • Transanal Surgery
  • Pandemic Healthcare

Background:

  • The coronavirus disease 2019 (COVID-19) pandemic necessitated adaptations in healthcare delivery, including specialized care for patients and healthcare workers.
  • The pandemic highlighted unique challenges and requirements for different surgical procedures and approaches in colorectal surgery.

Purpose of the Study:

  • To conduct a dynamic review on the application of robotic and transanal approaches for colorectal diseases during the COVID-19 pandemic.
  • To synthesize current evidence and recommendations regarding the safe performance of these minimally invasive techniques in a pandemic setting.

Main Methods:

  • A comprehensive literature search was performed on PubMed and KSREvidence.com for studies on COVID-19 and robotic surgery, transanal mesorectal excision, or transanal surgery.
  • Included were primary studies and systematic reviews. References from identified papers were also screened. European Society of Coloproctology guidelines were incorporated.

Main Results:

  • Eleven studies were included from PubMed after screening 147 results. No relevant systematic reviews were identified from KSREvidence.com.
  • Robotic and transanal minimally invasive surgery (MIS) approaches were found to be performable safely during the pandemic.
  • Specific characteristics and considerations unique to these procedures during a pandemic were identified.

Conclusions:

  • Robotic and transanal MIS are viable and safe options for colorectal disease management during the COVID-19 pandemic.
  • Adherence to specific procedural considerations is crucial for ensuring the safety of both patients and healthcare professionals when utilizing these techniques.